Adverse Events in a Trial Using a Running Period

There were a lot of adverse events listed, and it was all kind of clumped together. What we don't know from that table in the paper is at what dose those adverse effects occurred. And i would be interested to know whether patients who experienced hypocolenia, hypomagnes mia were patients who had been titrated all the way up to 50 milligrams a day or if those phenomena were seen at lower doses as well.